Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib (Q39366976)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib |
scientific article |
Statements
1 reference
Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib (English)
1 reference
Marek Brzosko
1 reference
Reiner Lehmann
1 reference
Petr Kopsa
1 reference
Ruth Nischik
1 reference
Andreas Kreisse
1 reference
Helen Thurston
1 reference
Stephane Litschig
1 reference
Victor S Sloan
1 reference
1 April 2005
1 reference
1 reference
Identifiers
1 reference